I agree. This reads well. There are so many things going on, and revenue seems to be gaining traction. Once it achieves CF+, will support their drug development program (much like CUV). With ~30ml in cash, and a current revenue run rate of ~16ml, at a 47ml EV, puts it on ~3 times revenue. This looks like good value for a unique offering company with lots of levers to the upside.
- Forums
- ASX - By Stock
- Ann: Q3 FY24 Quarterly Investor Presentation
MAP
microba life sciences limited
Add to My Watchlist
4.17%
!
9.2¢

I agree. This reads well. There are so many things going on, and...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
9.2¢ |
Change
-0.004(4.17%) |
Mkt cap ! $47.38M |
Open | High | Low | Value | Volume |
9.6¢ | 9.6¢ | 9.2¢ | $11.09K | 118.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 20774 | 9.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.5¢ | 114482 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 20774 | 0.092 |
4 | 60967 | 0.091 |
7 | 405677 | 0.090 |
2 | 192844 | 0.089 |
2 | 12552 | 0.088 |
Price($) | Vol. | No. |
---|---|---|
0.095 | 114482 | 1 |
0.099 | 88000 | 1 |
0.100 | 100000 | 1 |
0.105 | 103000 | 1 |
0.110 | 1714 | 1 |
Last trade - 15.11pm 29/07/2025 (20 minute delay) ? |
Featured News
MAP (ASX) Chart |